Brazil regulator may ease registration; WebMD new app for personal health; NIH launches website for 3-D printing research;

@FierceMedDev: EnteroMedics up in early trading after mixed FDA panel vote. More | Follow @FierceMedDev

@StacyALawrence: Medtronic merger could give Covidien execs an $80M payout. Story | Follow @StacyALawrence

@MichaelGFierce: UPenn team combats Parkinson's with immunotherapy that targets neuron killers. Story from FierceBiotechResearch | Follow @MichaelGFierce

@EmilyWFierce: Single gene mutations that lower triglyceride levels could spur the development of a new class of heart disease drugs. Article | Follow @EmilyWFierce

> Brazilian med device regulators are having public consultations on proposals that could ease registration and re-registration requirements for Class I and II devices. More

> WebMD released its Healthy Target iPhone app to send biometric data to physicians so that patients can more easily monitor conditions such as Type 2 diabetes. Release

> The NIH launched a public website that promotes health and science applications of 3D printing for students and researchers. More

Biotech News

@FierceBiotech: Navitor grabs a $23.5M A round to tackle a key crossroad for disease. More | Follow @FierceBiotech

@JohnCFierce: Man, that Burrill lawsuit makes for interesting reading. Story | Follow @JohnCFierce

@DamianFierce: J&J Innovation's summer class of biotechs targets obesity, insomnia, heart failure, cancer and more. News | Follow @DamianFierce

> Zafgen, Ardelyx bank $156M in IPOs, recalling biotech's winter boom. More

> J&J pays $30M to grab rights to Vertex program. Item

> Takeda dumps its top cancer contender after a late-stage struggle. Story

Pharma News

@FiercePharma: Now out: This week's issue of FierceVaccinesWeekly report | Follow @FiercePharma

@TracyStaton: Trending now at FiercePharma: Novo Nordisk lays out plans to recruit 6,000 workers in R&D, production. Story | Follow @TracyStaton

@EricPFierce: How much are the big dogs of Big Pharma paid? A lot. See the top 15 highest paid CEOs here. | Follow @EricPFierce

@CarlyHFierce: Czech scientists have a Lyme disease vaccine ready for animal use. A few of my favorite things in here, and Lyme disease isn't one of them. Story | Follow @CarlyHFierce

> J&J Innovation spotlights its slate of new biotech deals. Item

> Want a Big Pharma job? Apply in an emerging market--or think smaller. More

> Study: Suicides rise in wake of 'black box' warnings on antidepressants. Article

Vaccines News

> Merck, Sanofi JV wins anal cancer indication for Gardasil in EU. Story

> Themis Chikungunya prophylactic hits Phase I goal. More

> Pfizer puts the heat on Novartis with FDA MenB filing. Article

> Novartis submits Bexsero to FDA in race for MenB market. News

> MenB survivors call for Bexsero coverage in Australia. Item

> Novartis facility grabs FDA license to produce cell-culture vaccines. Report

Pharma Manufacturing News

> EMA GMP inspectors working group making updates for this year. Item

> Ranbaxy's FDA problems stymie launch of generic Nexium and the relief it would bring to consumers. More

> Dr. Reddy's initiates 2 recalls even as it invests to remove human error. Story

> Grifols doubles capacity with new U.S. plasma fractionation plant. Article

> Counterfeit antibiotics feed drug resistance, superbugs. News

> FDA finds fault with Chinese API maker. Report

Suggested Articles

The FDA has cleared its first fully disposable duodenoscope, following years of reports of infections being transmitted between patients.

OR-focused AI provider Caresyntax has garnered $45.6 million in new funding and picked up a data analytics firm to broaden its footprint.

A study of Foundation Medicine’s FoundationOne liquid biopsy test found it was able to predict the risk that a person’s breast cancer would return.